Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Brief description of study
The purpose of this study is to learn more about whether nebulized hypertonic saline can help improve symptoms and clearance of mycobacteria. Hypertonic saline (7% solution) for inhalation is sometimes prescribed to patients with MAC lung infections. We also want to learn how much of a burden this treatment is for participants with MAC.
Clinical Study Identifier: s21-00922
ClinicalTrials.gov Identifier: NCT04921943
Principal Investigator:
Doreen J Addrizzo-Harris.
Other Investigator:
Rudra Ramanathan.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
